Aubrey Wood

COO | Part-Owner

Aubrey brings a background in content and management to her role at Stock Analysis, where she leads operations and co-curates the Market Bullets newsletter. She spends her free time with her family and animals, often on long walks in nature. Aubrey holds degrees in professional writing and communication.

Written by Aubrey

Novartis' Kisqali reduces risk of death by 19.1% in 6-year breast cancer study

Novartis reported positive 6-year trial results for its breast cancer drug, Kisqali, showing improved survival rates of 19.1% and lasting benefits from treatment.

2 days ago

Meta reports $64.6B in Q3 revenue; announces non-voting Class C shares

Meta reported $64.60B in Q3 revenue, up 26% YoY and beating expectations, as well as plans for a new, non-voting Class C stock. The company is also facing two legal fines.

3 days ago

Amazon plans €16B+ German investment in 2027, including major AWS expansion

Amazon will invest €16B (approx. $18B USD) in Germany in 2027 to expand its cloud services, AI infrastructure, and more. AWS will get €4.8B, which will be focused on the Frankfurt region.

5 days ago

Industrial production rose 0.7% in September, Federal Reserve reports

The Federal Reserve reported today that U.S. industrial production rose 0.7% in September, up from 0.1% in August. This is the largest monthly increase since April's 0.8% rise.

9 days ago

Apple hits $5T milestone for the first time — shares close at $342.96

On Wednesday, October 14, Apple ($AAPL) closed above $5T for the first time. Shares finished the session at $342.96, +$1.69 (0.50%) for the day.

10 days ago

Nike revenue falls 4% to $11.2B, missing estimates; company announces restructuring plan

Nike ($NKE) reported $11.21B in Q1 FY2027 earnings, coming in below estimates, and announced "major changes to its operating model." It also forecasts a FY2027 sales decline in the high-single digits.

23 days ago

Lilly's new weight loss combo drug outperforms tirzepatide in latest trial

Eli Lilly reported positive results from a study following EloraTZP, its experimental combo weight loss drug, noting that patients lost an average of 23.3% of their body weight.

25 days ago

Tesla secures $30B in new credit, though doesn't plan to use it in 2026

Tesla has secured up to $30B in new credit facilities, significantly expanding its access to capital, though says it doesn't plan to draw on the credit in 2026.

25 days ago

RTX's Raytheon awarded 5-year defense contract worth up to $20.7B

Raytheon, a subsidiary of RTX ($RTX), has secured a government contract worth up to $20.7B to significantly increase production of medium-range air missiles.

26 days ago

Trump administration overhauls vehicle fuel economy rules, lowering standards

The Trump administration has reversed a Biden-era policy intended to make vehicles more fuel efficient. The new rules are expected to lower vehicle costs but raise emissions.

27 days ago

Starbucks plans to shutter about 250 locations, will take $300M in charges

Starbucks will close about 250 of its North American stores, a plan that will cost approximately $300M in restructuring charges. The 250 stores represent 1% of the company's 18,000 North American locations.

4 weeks ago

Global debt surpasses $365T, hitting a new record, IIF report says

The Institute of International Finance, or IIF, says global debt increased by $10T in the first half of 2026, surpassing $365T in total, with emerging markets accounting for much of the increase.

4 weeks ago

Viking Therapeutics stock jumps 36% as weight loss drug shows lasting benefits with fewer doses

Viking Therapeutics ($VKTX) stock soared 35.67% on Tuesday after the company reported promising results from a study examining maintenance doses of its experimental weight loss shot, VK2735.

4 weeks ago

Fed returns to rate hikes after 3-year pause, raising its key interest rate by 0.25 percentage points

The Federal Reserve voted 12-0 on Sept. 16 to raise the federal funds target 25 bp to 3.75%–4.00%, the first hike since 2023. The median year-end 2026 funds-rate projection rose to 4.1%, up from 3.8% in June.

5 weeks ago

EU plans sweeping new limits on social media for minors

The EU is preparing new rules to limit how children and teenagers use social media, gaming platforms, and AI chatbots. The act is expected to be introduced on Thursday.

5 weeks ago